Biocorrx Inc. (OTCMKTS:BICX – Get Free Report)’s stock price passed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $0.33 and traded as high as $0.38. Biocorrx shares last traded at $0.38, with a volume of 377 shares changing hands.
Biocorrx Stock Performance
The company has a market capitalization of $9.31 million, a P/E ratio of -1.19 and a beta of 0.27. The firm’s fifty day moving average is $0.33 and its 200-day moving average is $0.37.
Biocorrx (OTCMKTS:BICX – Get Free Report) last released its quarterly earnings results on Friday, November 14th. The company reported ($0.11) earnings per share for the quarter, missing the consensus estimate of ($0.06) by ($0.05). The firm had revenue of $0.63 million during the quarter, compared to the consensus estimate of $0.19 million.
About Biocorrx
BioCorRx Inc, through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition.
Featured Articles
- Five stocks we like better than Biocorrx
- America’s Next Power Move Starts Underground
- Your Signature Is Missing – Act Before It’s Too Late
- URGENT: Trump Just Triggered AI’s Biggest Disruption Yet
- NEW LAW: Congress Approves Setup For Digital Dollar?
- BSEM: A $25.50 Price Target, and Nasdaq on the Horizon!
Receive News & Ratings for Biocorrx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biocorrx and related companies with MarketBeat.com's FREE daily email newsletter.
